ADMS - Adamas Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts99109
Avg. Estimate-1.15-1.1-4.28-2.53
Low Estimate-1.31-1.21-4.6-3.73
High Estimate-1.07-0.85-3.65-1.5
Year Ago EPS-1.35-1.26-4.87-4.28
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts99108
Avg. Estimate12.31M13.9M59.76M110.18M
Low Estimate9M11M54.1M82.1M
High Estimate14.22M15.4M65.97M166.08M
Year Ago Sales2.55M7.57M34.05M59.76M
Sales Growth (year/est)382.20%83.70%75.50%84.40%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-1.37-1.41-1.34-1.34
EPS Actual-1.35-1.26-1.22-1.06
Difference0.020.150.120.28
Surprise %1.50%10.60%9.00%20.90%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.15-1.1-4.28-2.53
7 Days Ago-1.15-1.12-4.28-2.52
30 Days Ago-1.15-1.12-4.28-2.52
60 Days Ago-1.22-1.17-4.38-2.14
90 Days Ago-1.21-1.15-4.33-2.07
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A11
Growth EstimatesADMSIndustrySectorS&P 500
Current Qtr.14.80%N/AN/A-0.01
Next Qtr.12.70%N/AN/A0.04
Current Year12.10%N/AN/A0.05
Next Year40.90%N/AN/A0.11
Next 5 Years (per annum)17.90%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A